Production & Manufacturing
TaiGen Biotechnology Out-Licenses Taigexyn® (Nemonoxacin) to Productos Científicos for the Latin American Market
TaiGen Biotechnology Company, Limited announced that they have signed an exclusive licensing agreement with Productos Científicos S.A. de C.V. ("PC"), a leading Mexican pharmaceutical...
Drug Research
Nymox Pharmaceutical Reports Successful New Long-Term Fexapotide Placebo Crossover Study Results
Nymox Pharmaceutical Corp is pleased to announce successful new study results from the long-term blinded placebo crossover group from the U.S. Phase 3 trials...
Industry Reports
Ball Corporation Publishes 2016 Sustainability Report
Ball Corporation published its fifth biennial sustainability report, which details the company's progress toward its updated priorities – product stewardship, operational excellence, talent management...
Clinical Trials
CSM To Host A Live Webinar On Direct-To-Patient Shipping For Clinical Trials
CSM, a leading provider of clinical trial supply services, will conduct an upcoming webinar, "Discover How Direct-to-Patient Shipping is Changing Clinical Trials." ...
Industry Reports
Pfizer to buy antibiotics business from AstraZeneca
Pfizer Inc announced that it has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage small molecule...
Press Releases
Vital to Showcase Enterprise Interoperability for Improved Clinical Care and Business Intelligence at HIMSS Asia Pacific
Vital Images, Inc. a Minneapolis-based advanced medical imaging and informatics company, will feature its enterprise interoperability solutions at the HIMSS Asia Pacific annual conference...
News
Bristol-Myers Squibb and Pfizer to Present New Eliquis Analyses at ESC Congress 2016
Bristol-Myers Squibb Company and Pfizer Inc announced that 19 abstracts (late-breaking, rapid-fire, oral and poster presentations) will be presented at ESC Congress 2016, to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read